학술논문
Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
02507005